IPO overvaluation continues to destroy investor wealth while underwriters, analysts, and founders face almost no personal accountability. The pattern is familiar: hype-driven pricing, sharp post-listing collapses, and a regulatory framework that punishes disclosure failures, not valuation excess.

High profile IPO failures: the pattern of hype and collapse

Across major IPOs, the same story repeats:

• WeWork (2019): Valuation cut from 47 billion dollars to below 10 billion dollars. IPO withdrawn. No SEC penalties for underwriters.

• Facebook (2012): Priced at 38 dollars. Fell more than 30 percent within weeks. Only firm-level settlements.

• Uber (2019): Listed at 82 billion dollars. Stock dropped immediately and kept falling. No valuation-related sanctions.

• Rivian (2021): Briefly hit 150 billion dollars with minimal revenue. Later fell more than 80 percent. Underwriters kept fees.

• Grab (2021 SPAC): Fell 21 percent on day one. No accountability triggered.

Historical examples reinforce the pattern: Vonage, TheGlobe.com, Pets.com, Webvan, and Casper. All aggressively priced. All collapsed. None resulted in meaningful personal consequences.

Who sets the price and who pays the price

Underwriters lead valuation through book-building, comparables, and investor demand. Founders often push higher, but banks ultimately sign off.

Oversight remains weak:

• The SEC reviews disclosures, not valuation accuracy.

• FINRA enforces conduct rules, not pricing discipline.

• Section 11 liability applies to factual misstatements, not valuation opinions.

• Penalties, when they occur, hit firms, not individuals.

The result is an asymmetric incentive structure where banks earn fees upfront and investors absorb losses later.

The greed factor: how incentives distort valuations

A significant part of the problem is the excessive greed embedded in the IPO process. This manifests in predictable ways. Founders and early investors often treat the IPO as a cash-out event, aiming to sell shares at the highest possible price after years of private ownership. Growth prospects are frequently overhyped, with marketing and buzz overwhelming fundamentals and profitability.

Bankers further inflate valuations by layering in complex financial jargon that appears sophisticated but often serves to justify higher numbers. Terms such as value at risk, control premium, network effects, optionality, total addressable market expansion, platform synergies, intangible asset uplift, and future margin scalability are commonly inserted into valuation models. Many of these assumptions are highly subjective and can be stretched to produce almost any valuation outcome the issuer prefers.

This complexity makes it difficult for retail investors to challenge the narrative while giving bankers a technical shield to defend inflated pricing that later proves unsustainable in public markets. Information asymmetry gives insiders a clear advantage, allowing elevated prices that retail investors, driven by FOMO, are willing to pay. The result is attractive day-one pricing followed by poor long-term performance.

The hype does not stop at IPO

Overvaluation often persists after listing through analyst optimism and momentum trading. Some companies trade at price-to-earnings ratios above 100 or revenue multiples above 50 despite modest fundamentals.

Examples include:

• Tesla with a P E ratio above 300

• Broadcom with a P E ratio above 87

• Eli Lilly with a P E ratio above 51

• Repligen with a P E ratio above 7,800

• Warby Parker with a P E ratio above 2,700

These valuations are not supported by proportionate earnings growth. When sentiment turns, stocks collapse, erasing billions in market value. Analysts who promoted the narrative and bankers who supported inflated expectations face no personal consequences. The accountability gap is systemic, not episodic.

Best practices that reduce hype but are not mandatory

Some firms already follow stronger valuation discipline:

• Early IPO readiness and recurring independent valuations

• Multi-method valuation using DCF, comparables, and precedents

• Focus on fundamentals such as cash flow, unit economics, and sustainable growth

• Deep due diligence and transparent assumptions

• Independent fairness or solvency opinions from firms like Kroll or Houlihan Lokey

• Big Four assurance on financials and risk disclosures

These practices are effective but remain optional and are often overridden by commercial pressure.

What needs to change: real oversight and real consequences

IPO overvaluation has been a predictable failure for decades. Investors absorb the losses, while underwriters and analysts walk away with fees and minimal accountability. Disclosure-based regulation alone has proven insufficient.

To realign incentives, markets need transparency and personal responsibility. This includes publishing underwriter post-IPO performance, mandating independent valuation for high-risk issuers, linking banker compensation to post-listing performance, and expanding personal liability for reckless or negligent valuations. Clearer regulatory guidance from the SEC and FINRA is also essential.

Without real consequences, the cycle will continue. Trust will erode, capital allocation will suffer, and IPO markets will fail to serve investors as intended.

A question worth asking

When IPO valuations fail, it is rarely accidental.
So who should be accountable for valuation excess, and what consequences, if any, should follow?